|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wu X, Zhao H, Suk R and Christiani DC:
Genetic susceptibility to tobacco-related cancer. Oncogene.
23:6500–6523. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vachani A, Sequist LV and Spira A: AJRCCM:
100-Year anniversary. The shifting landscape for lung cancer: Past,
present, and future. Am J Respir Crit Care Med. 195:1150–1160.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Anand P, Kunnumakkara AB, Sundaram C,
Harikumar KB, Tharakan ST, Lai OS, Sung B and Aggarwal BB: Cancer
is a preventable disease that requires major lifestyle changes.
Pharm Res. 25:2097–2116. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Aird I, Bentall HH and Roberts JA: A
relationship between cancer of stomach and the ABO blood groups. Br
Med J. 1:799–801. 1953. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hems G: Epidemiological characteristics of
breast cancer in middle and late age. Br J Cancer. 24:226–234.
1970. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vioque J and Walker AM: Pancreatic cancer
and ABO blood types: A study of cases and controls. Med Clin
(Barc). 96:761–764. 1991.(In Spanish). PubMed/NCBI
|
|
8
|
Melzer D, Perry JR, Hernandez D, Corsi AM,
Stevens K, Rafferty I, Lauretani F, Murray A, Gibbs JR, Paolisso G,
et al: A genome-wide association study identifies protein
quantitative trait loci (pQTLs). PLoS Genet. 4:e10000722008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Barbalic M, Dupuis J, Dehghan A, Bis JC,
Hoogeveen RC, Schnabel RB, Nambi V, Bretler M, Smith NL, Peters A,
et al: Large-scale genomic studies reveal central role of ABO in
sP-selectin and sICAM-1 levels. Hum Mol Genet. 19:1863–1872. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Paterson AD, Lopes-Virella MF, Waggott D,
Boright AP, Hosseini SM, Carter RE, Shen E, Mirea L, Bharaj B, Sun
L, et al: Genome-wide association identifies the ABO blood group as
a major locus associated with serum levels of soluble E-selectin.
Arterioscler Thromb Vasc Biol. 29:1958–1967. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qi L, Cornelis MC, Kraft P, Jensen M, van
Dam RM, Sun Q, Girman CJ, Laurie CC, Mirel DB, Hunter DJ, et al:
Genetic variants in ABO blood group region, plasma soluble
E-selectin levels and risk of type 2 diabetes. Hum Mol Genet.
19:1856–1862. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vowden P, Lowe AD, Lennox ES and Bleehen
NM: The expression of ABH and Y blood group antigens in benign and
malignant breast tissue: The preservation of the H and Y antigens
in malignant epithelium. Br J Cancer. 53:313–319. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Strauchen JA, Bergman SM and Hanson TA:
Expression of A and B tissue isoantigens in benign and malignant
lesions of the breast. Cancer. 45:2149–2155. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Le Pendu J, Marionneau S, Cailleau-Thomas
A, Rocher J, Le Moullac-Vaidye B and Clément M: ABH and Lewis
histo-blood group antigens in cancer. APMIS. 109:9–31. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Urun Y, Utkan G, Cangir AK, Oksuzoglu OB,
Ozdemir N, Oztuna DG, Kocaman G, Coşkun HŞ, Kaplan MA, Yuksel C, et
al: Association of ABO blood group and risk of lung cancer in a
multicenter study in Turkey. Asian Pac J Cancer Prev. 14:2801–2803.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Peng M, Yu S, Wang J and Wang D:
Relationship between ABO blood group and risk of 8 kinds of
malignant tumors. Chin J Health Inspection. 24:811–813+823.
2014.(In Chinese).
|
|
17
|
Wells G, Shea B, O'Connell D, Peterson J,
Welch V, Losos M and Tugwell P: The Newcastle-Ottawa scale (NOS)
for assessing the quality of non-randomized studies in
meta-analysis. Appl Eng Agric. 18:727–734. 2014.https://www.ohri.ca/programs/clinical_epidemiology/oxford.aspMarch
2–2022
|
|
18
|
Thorlund K, Engstrøm J, Wetterslev J, Brok
J, Imberger G and Gluud C: User Manual for Trial Sequential
Analysis (TSA). 2nd edition. Copenhagen: Copenhagen Trial Unit; pp.
1–119. 2017
|
|
19
|
Xu A, He X, Wang W, Tang Y and Ping W:
Relationship between ABO blood group and gastric cancer, liver
cancer and lung cancer. J Clin Mil Med. 722–723. 2006.(In
Chinese).
|
|
20
|
Oguz A, Unal D, Tasdemir A, Karahan S,
Aykas F, Mutlu H, Cihan YB and Kanbay M: Lack of any association
between blood groups and lung cancer, independent of histology.
Asian Pac J Cancer Prev. 14:453–456. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li B, Tan B, Chen C, Zhao L and Qin L:
Association between the ABO blood group and risk of common cancers.
J Evid Based Med. 7:79–83. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sun B and Zheng Y: ABO blood group typing
in lung cancer patients. J Clin Pulmonology. 2:302001.(In
Chinese).
|
|
23
|
Yang C, Zhang R, Zhou S and Wang Q:
Discussion on the relationship between ABO blood group and lung
cancer, liver cancer and gastric cancer. Clin Transfus Lab.
1:11–12. 2000.(In Chinese).
|
|
24
|
Li J, Hu J and Wang M: The correlation
between esophageal cancer, lung cancer and ABO blood group. Chin J
Blood Transfus. 1:45–46. 1995.(In Chinese).
|
|
25
|
Wang H and Liang X: Relationship between
ABO blood group and 10 kinds of malignant tumors of Han nationality
in Guangxi. Med Lit. 5:643–644. 2000.(In Chinese).
|
|
26
|
Gao H, Zhao L, Wu S, Wang D, Li Y and
Heyun S: Relationship between malignant tumor and ABO blood group.
Chin J Prim Med. 4:41–42. 1998.(In Chinese).
|
|
27
|
Xiao H, Xiang S, Shan Z and Bin X:
Relationship between ABO blood group and different pathological
types of lung cancer in southern Sichuan. Chin J Mod Med.
31:98–102. 2021.(In Chinese).
|
|
28
|
Huang JY, Wang R, Gao YT and Yuan JM: ABO
blood type and the risk of cancer-findings from the Shanghai cohort
study. PLoS One. 12:e01842952017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Feng J and Ying X: Correlation analysis
between ABO blood group and lung cancer in Zhejiang Han people.
Harbin Med. 33:96–97. 2013.(In Chinese).
|
|
30
|
Chen L, Heng C, Shen W and Xiao X:
Correlation analysis between ABO blood group and malignant tumor.
Chin J Oncol. 3:131–133. 2004.(In Chinese).
|
|
31
|
Hsiao LT, Liu NJ, You SL and Hwang LC: ABO
blood group and the risk of cancer among middle-aged people in
Taiwan. Asia Pac J Clin Oncol. 11:e31–e36. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tang L, Ren Z, Zhou X, Su Z and Zhuang Z:
ABO blood group and its interaction with smoking and lung cancer
susceptibility. Chronic Dis Prev Control China. 2:70–71. 2001.(In
Chinese).
|
|
33
|
McConnell RB, Clarke CA and Downton F:
Blood groups in carcinoma of the lung. Br Med J. 2:323–325. 1954.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhao P, Wu Q and Wang S: Lung cancer and
ABO blood group relationship. Chin J Eugenics Genet. 59–60.
1993.(In Chinese).
|
|
35
|
Rennie HM and Haber RW: Blood groups and
carcinoma of the lung. Med J Aust. 48:61–62. 1961. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jiang T and Wang Z: ABO blood group
distribution in 288 patients with lung cancer. J Chongqing Med
Univ. 220–221. 1989.(In Chinese).
|
|
37
|
Pan T, Zheng Z, Li J, Chen T, Wei X, Hu M
and Liu L: ABO blood group and lung cancer in Hubei province and
literature review. Sixth National Thoracic and Cardiovascular
Surgery Conference; Beijing, China: pp. 22006, (In Chinese).
PubMed/NCBI
|
|
38
|
Sun W, Wen CP, Lin J, Wen C, Pu X, Huang
M, Tsai MK, Tsao CK, Wu X and Chow WH: ABO blood types and cancer
risk-a cohort study of 339,432 subjects in Taiwan. Cancer
Epidemiol. 39:150–156. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu X, Chen X, Yang J and Guo R:
Association of ABO blood groups with von Willebrand factor, factor
VIII and ADAMTS-13 in patients with lung cancer. Oncol Lett.
14:3787–3794. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhang YW: Preliminary analysis of ABO
blood group distribution in cancer patients. J Hubei Med Coll.
369–371. 1990.(In Chinese).
|
|
41
|
Jin YY, Wang ZY and Cheng CH: Relationship
between ABO blood group and 3 common cancers. J Luoyang Med Coll.
3:2482000.(In Chinese).
|
|
42
|
Guo ZH: Lung cancer and ABO blood group.
Chin J Mod Med. 1:61–63. 2001.(In Chinese).
|
|
43
|
Liu Z, Qiao Z and Huang P: Association
between ABO blood group and lung cancer. Mod Med Health.
14:2134–2135. 2006.(In Chinese).
|
|
44
|
Cai Z, Fang W, Qin J, Chen S and Lai K:
Correlation between ABO blood group and malignant tumors in
Guangzhou area. J Appl Med Technol. 21:3727–3729. 2006.(In
Chinese).
|
|
45
|
Wang Z: ABO blood group distribution
analysis of lung cancer patients. Shaanxi Med Lab. 242–243.
1993.(In Chinese).
|
|
46
|
Landsteiner K: ZTo know the
antifermentative, lytic and agglutinative effects of blood serum
and lymph. Centr Bakt Orig. 27:357–362. 1900.(In German).
|
|
47
|
Landsteiner K: About agglutination
symptoms of normal human blood. Wien Klin Wochschr. 14:1132–1134.
1901.(In German).
|
|
48
|
Wagner FF, Flegel WA, Bittner R and
Döscher A: Molecular typing for blood group antigens within 40 min
by direct polymerase chain reaction from plasma or serum. Br J
Haematol. 176:814–821. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Tang Z: Introduction to modern oncology.
Med Res Lett. 242001.
|
|
50
|
Hakomori S: Antigen structure and genetic
basis of histo-blood groups A, B and O: Their changes associated
with human cancer. Biochim Biophys Acta. 1473:247–266. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zhang S, Zhang HS, Cordon-Cardo C, Reuter
VE, Singhal AK, Lloyd KO and Livingston PO: Selection of tumor
antigens as targets for immune attack using immunohistochemistry:
II. Blood group-related antigens. Int J Cancer. 73:50–56. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Marionneau S, Le Moullac-Vaidye B and Le
Pendu J: Expression of histo-blood group A antigen increases
resistance to apoptosis and facilitates escape from immune control
of rat colon carcinoma cells. Glycobiology. 12:851–856. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Sequist LV and Lynch TJ: EGFR tyrosine
kinase inhibitors in lung cancer: An evolving story. Annu Rev Med.
59:429–442. 2008. View Article : Google Scholar : PubMed/NCBI
|
